Julia O’Lynn
Imaging Expert | Business Development
Imaging Clinical Research Expert
Julia O'Lynn is a medical imaging expert with over 20 years of experience in advanced radiologic imaging and targeted drug development. She currently serves as the Director of Imaging at Image Analysis Group (IAG), where she specializes in advising life science companies on accelerating drug development and ensuring standardized imaging across multi-center clinical trials14.
O'Lynn's expertise includes:
Radiologic cross-sectional imaging
Clinical trial design
Imaging-based markers for drug development
Standardization of imaging in multi-center trials
With a focus on neuro-oncology, O'Lynn helps build biotech partnerships that explore how advanced analysis, AI, and precision medicine can determine early efficacy in clinical trials. Her role at IAG involves leveraging technology and AI to optimize clinical trials and accelerate drug development.
O'Lynn frequently participates in industry events and webinars, sharing her knowledge on topics such as response prediction in oncology clinical trials and the use of quantitative imaging methods to address limitations in current assessment criteria like RECIST and RANO
IAG, Image Analysis Group
Our next-gen platform, R&D and service divisions together with funding mechanisms holistically address the broader issues experienced by biopharma with active and often complex clinical trial pipelines by providing an integrated approach to clinical development and strategic planning.
Image Management Platform
Real-time information, patented data analysis methodologies, flexible reporting options for all stakeholders ensure transparency of trial process and the use of the latest scientific innovation in proving efficacy of your novel treatments.
Careers
In addition to specific listed roles, we are always looking for biotech and pharma experts and enthusiasts with entrepreneurial mindset, can-do attitude and solid scientific background.